- Home
- GRYP vs CRIS Comparison
GRYP vs CRIS Comparison
Compare GRYP & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRYP
- CRIS
- Stock Information
- Founded
- GRYP 2010
- CRIS 2000
- Country
- GRYP United States
- CRIS United States
- Employees
- GRYP N/A
- CRIS N/A
- Industry
- GRYP
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRYP
- CRIS Health Care
- Exchange
- GRYP Nasdaq
- CRIS Nasdaq
- Market Cap
- GRYP 14.9M
- CRIS 13.5M
- IPO Year
- GRYP N/A
- CRIS 2000
- Fundamental
- Price
- GRYP $1.20
- CRIS $2.46
- Analyst Decision
- GRYP Hold
- CRIS Strong Buy
- Analyst Count
- GRYP 1
- CRIS 2
- Target Price
- GRYP N/A
- CRIS $16.50
- AVG Volume (30 Days)
- GRYP 34.0M
- CRIS 89.6K
- Earning Date
- GRYP 05-15-2025
- CRIS 05-06-2025
- Dividend Yield
- GRYP N/A
- CRIS N/A
- EPS Growth
- GRYP N/A
- CRIS N/A
- EPS
- GRYP N/A
- CRIS N/A
- Revenue
- GRYP $14,607,000.00
- CRIS $11,202,000.00
- Revenue This Year
- GRYP N/A
- CRIS $2.15
- Revenue Next Year
- GRYP N/A
- CRIS $5.08
- P/E Ratio
- GRYP N/A
- CRIS N/A
- Revenue Growth
- GRYP N/A
- CRIS 14.17
- 52 Week Low
- GRYP $0.13
- CRIS $1.02
- 52 Week High
- GRYP $2.93
- CRIS $10.99
- Technical
- Relative Strength Index (RSI)
- GRYP 60.32
- CRIS 65.60
- Support Level
- GRYP $1.13
- CRIS $1.92
- Resistance Level
- GRYP $1.38
- CRIS $2.19
- Average True Range (ATR)
- GRYP 0.38
- CRIS 0.21
- MACD
- GRYP -0.02
- CRIS 0.03
- Stochastic Oscillator
- GRYP 22.77
- CRIS 100.00
About GRYP Gryphon Digital Mining Inc Common Stock
Gryphon Digital Mining Inc is a Bitcoin mining company. Gryphon's mission is to create the world's leading net carbon-neutral Bitcoin miner. The company will operate a digital asset, mining operation using specialized computers equipped with application-specific integrated circuit (ASIC) chips to solve complex cryptographic algorithms in support of the Bitcoin blockchain in exchange for cryptocurrency rewards (primarily Bitcoin).
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.